The Restrictive Red Blood Cell Transfusion Strategy for Critically Injured Patients (RESTRIC) trial: a cluster-randomized, crossover, non-inferiority multicenter trial of restrictive transfusion in trauma.

Mineji HayakawaTakashi TagamiDaisuke KudoKota OnoMakoto AokiAkira EndoTetsuya YumotoYosuke MatsumuraShiho IrinoKazuhiko SekineNoritaka UshioTakayuki OguraSho NachiYuhei IrieKatsura HayakawaYusuke ItoYuko OkishioTomohiro MuronoiYoshinori KosakiKaori ItoKeita NakatsutsumiYutaka KondoTaichiro UedaHiroshi FukumaYuichi SaisakaNaoki TominagaTakeo KuritaFumihiko NakayamaTomotaka ShibataShigeki Kushimoto

Published in: Journal of intensive care (2023)

umin.ac.jp/ctr: UMIN000034405, registration date: 8 October 2018.

Keyphrases

phase iii
double blind
red blood cell
phase ii
open label
end stage renal disease
placebo controlled
clinical trial
study protocol
ejection fraction
cardiac surgery
chronic kidney disease
prognostic factors
randomized controlled trial
peritoneal dialysis
sickle cell disease
cross sectional
trauma patients